Theodore Samuels, II Biography and Net Worth

Director of Perrigo


Theodore R. Samuels has been a director of Perrigo since January 2017. From 1981 to 2017, Mr. Samuels was an investor at Capital Group, a financial services company, and he served as President of Capital Guardian Trust Company, an affiliated company of Capital Group, from 2010 to 2016. While at Capital Group, he also served on The Capital Group board, audit committee and finance committee, as well as on numerous management and investment committees. Mr. Samuels has been a director for Stamps.com since January 2017 and a director of Bristol-Myers Squibb since February 2017.

What is Theodore R. Samuels, II's net worth?

The estimated net worth of Theodore R. Samuels, II is at least $1.09 million as of November 20th, 2023. Mr. Samuels, II owns 35,500 shares of Perrigo stock worth more than $1,093,400 as of April 19th. This net worth evaluation does not reflect any other investments that Mr. Samuels, II may own. Learn More about Theodore R. Samuels, II's net worth.

How do I contact Theodore R. Samuels, II?

The corporate mailing address for Mr. Samuels, II and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Theodore R. Samuels, II's contact information.

Has Theodore R. Samuels, II been buying or selling shares of Perrigo?

Theodore R. Samuels, II has not been actively trading shares of Perrigo within the last three months. Most recently, on Monday, November 9th, Theodore R. Samuels II bought 4,500 shares of Perrigo stock. The stock was acquired at an average cost of $46.91 per share, with a total value of $211,095.00. Following the completion of the transaction, the director now directly owns 14,290 shares of the company's stock, valued at $670,343.90. Learn More on Theodore R. Samuels, II's trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (CEO), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 9 times. They purchased a total of 54,480 shares worth more than $1,599,465.50. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 197,646 shares worth more than $7,065,844.50. The most recent insider tranaction occured on March, 5th when EVP Alison Ives bought 2,490 shares worth more than $67,877.40. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 3/5/2024.

Theodore R. Samuels, II Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/9/2020Buy4,500$46.91$211,095.0014,290View SEC Filing Icon  
3/13/2020Buy2,000$42.50$85,000.008,236View SEC Filing Icon  
8/9/2019Buy4,000$46.97$187,880.008,236View SEC Filing Icon  
See Full Table

Theodore R. Samuels, II Buying and Selling Activity at Perrigo

This chart shows Theodore R Samuels II's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $30.80
Low: $29.82
High: $30.82

50 Day Range

MA: $30.64
Low: $26.22
High: $32.40

2 Week Range

Now: $30.80
Low: $25.77
High: $40.28

Volume

1,168,219 shs

Average Volume

1,859,462 shs

Market Capitalization

$4.17 billion

P/E Ratio

N/A

Dividend Yield

3.68%

Beta

0.64